Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors AM Farrar, KN Segovia, PA Randall, EJ Nunes, LE Collins, CM Stopper, ... Neuroscience 166 (4), 1056-1067, 2010 | 137 | 2010 |
Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis D Saredakis, LE Collins-Praino, DS Gutteridge, BCM Stephan, ... Parkinsonism & related disorders 65, 20-31, 2019 | 129 | 2019 |
The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit … AM Mott, EJ Nunes, LE Collins, RG Port, KS Sink, J Hockemeyer, ... Psychopharmacology 204, 103-112, 2009 | 127 | 2009 |
Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism JD Salamone, AM Farrar, L Font, V Patel, DE Schlar, EJ Nunes, ... Behavioural brain research 201 (1), 216-222, 2009 | 120 | 2009 |
Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142 KS Sink, KN Segovia, J Sink, PA Randall, LE Collins, M Correa, ... European Neuropsychopharmacology 20 (2), 112-122, 2010 | 98 | 2010 |
Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury? LE Collins-Praino, F Corrigan Brain, behavior, and immunity 60, 369-382, 2017 | 92 | 2017 |
Soluble amyloid beta levels are elevated in the white matter of Alzheimer’s patients, independent of cortical plaque severity LE Collins-Praino, YI Francis, EY Griffith, AF Wiegman, J Urbach, ... Acta neuropathologica communications 2, 1-10, 2014 | 90 | 2014 |
APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role? AM Brickman, N Schupf, JJ Manly, Y Stern, JA Luchsinger, ... Alzheimer's & Dementia 10 (6), 619-629, 2014 | 85 | 2014 |
Neuroinflammation as a key driver of secondary neurodegeneration following stroke? SM Stuckey, LK Ong, LE Collins-Praino, RJ Turner International Journal of Molecular Sciences 22 (23), 13101, 2021 | 84 | 2021 |
Evolution and significance of the triple risk model in sudden infant death syndrome J Spinelli, L Collins‐Praino, C Van Den Heuvel, RW Byard Journal of paediatrics and child health 53 (2), 112-115, 2017 | 67 | 2017 |
The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats KS Sink, KN Segovia, LE Collins, EJ Markus, VK Vemuri, A Makriyannis, ... Pharmacology Biochemistry and Behavior 95 (4), 479-484, 2010 | 63 | 2010 |
Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: effects on locomotor activity LE Collins, DJ Galtieri, P Collins, SK Jones, RG Port, NE Paul, ... Behavioural brain research 211 (2), 148-155, 2010 | 60 | 2010 |
The effect of an acute systemic inflammatory insult on the chronic effects of a single mild traumatic brain injury LE Collins-Praino, A Arulsamy, V Katharesan, F Corrigan Behavioural brain research 336, 22-31, 2018 | 51 | 2018 |
Role of dopamine–adenosine interactions in the brain circuitry regulating effort-related decision making: insights into pathological aspects of motivation JD Salamone, M Correa, AM Farrar, EJ Nunes, LE Collins Future Neurology 5 (3), 377-392, 2010 | 48 | 2010 |
The novel adenosine A2A antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions JL Santerre, EJ Nunes, R Kovner, CE Leser, PA Randall, ... Pharmacology Biochemistry and Behavior 102 (4), 477-487, 2012 | 46 | 2012 |
Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor LE Collins-Praino, NE Paul, KL Rychalsky, JR Hinman, JJ Chrobak, ... Frontiers in systems neuroscience 5, 49, 2011 | 45 | 2011 |
Toll like receptor 4 activation can be either detrimental or beneficial following mild repetitive traumatic brain injury depending on timing of activation F Corrigan, A Arulsamy, LE Collins-Praino, JL Holmes, R Vink Brain, behavior, and immunity 64, 124-139, 2017 | 44 | 2017 |
The need to incorporate aged animals into the preclinical modeling of neurological conditions M Sun, SJ McDonald, RD Brady, L Collins-Praino, GR Yamakawa, ... Neuroscience & Biobehavioral Reviews 109, 114-128, 2020 | 41 | 2020 |
The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade LE Collins, TN Sager, AG Sams, A Pennarola, RG Port, M Shahriari, ... Pharmacology Biochemistry and Behavior 100 (3), 498-505, 2012 | 41 | 2012 |
More than motor impairment: A spatiotemporal analysis of cognitive impairment and associated neuropathological changes following cortical photothrombotic stroke S Sanchez-Bezanilla, RJ Hood, LE Collins-Praino, RJ Turner, FR Walker, ... Journal of Cerebral Blood Flow & Metabolism 41 (9), 2439-2455, 2021 | 35 | 2021 |